08:55 AM EDT, 06/09/2025 (MT Newswires) -- Health care stocks were steady premarket Monday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) recently inactive.

Merck ( MRK ) shares were up more than 2% after the company reported results from two phase 3 trials evaluating enlicitide decanoate, saying the investigational oral PCSK9 inhibitor showed statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol compared with placebo and other oral non-statin therapies.